Work with Matrix Screening

NCATS’ combination screening platform experts regularly collaborate with basic researchers and clinical investigators inside and outside the National Institutes of Health on an as-needed basis.

The NCATS team currently is working with investigators at the National Cancer Institute to screen for novel therapies targeting multiple cancer subtypes. View these projects

For more information about working with the matrix screening team at NCATS, contact Anna Rossoshek.